researchers are sounding the alarm that cisplatin — a life-saving chemotherapy drug known to cause hearing loss in children — does more damage the earlier in life it is administered.
the study,
published in the journal cancer
, said the drug, commonly used to treat a range of cancers in children, begins to take a toll on hearing soon after being administered, with older children less vulnerable to the same magnitude of loss.
“this is significant as even a moderate loss of hearing can impact social development in children, particularly when it occurs during a peak time of language acquisition,”
said bruce carleton
, senior author of the study, professor at university of british columbia’s department of pediatrics and an investigator and director of the pharmaceutical outcomes programme at bc children’s hospital.
ototoxicity, also known as ear poisoning, occurs when a person develops hearing or balance issues as a result of medication, often those used to treat cancer, illness or infection,
according to kids health
. symptoms are dictated by the extent of damage to the inner ear and can include tinnitus (ringing in the ear), major balance issues, hearing problems in both ears and even profound hearing loss. when detected early, doctors may be able to prevent the issue from worsening and prescribe therapies to manage the issue. while there is no sure way to reverse the effects of ototoxicity, the condition occasionally improves over time once the inner ear has had time to heal.